pharma x bpc 157 Congratulations to Dr. Maria Pino and Student Physician Sukhraj Singh on the publication of their latest article, "Heal or Harm: Body Protective Compound-157 in the Gray Zone," in Pharmacy Times. Their article BPC-157 | Wholesale Pricing

Returned to Category 1 compounding status in February 2026 Published literature: Extensive veterinary medicine literature plus preclinical studies on muscle, tendon, and cardiac tissue For the regulatory timeline including the February 2026 reclassification and current compounding eligibility see our TB-500 FDA approval status 2026 breakdown

The result is a dual-mechanism research tool whose effects can in principle exceed those of either component alone in research models where multiple repair pathways contribute to the outcome

What about sodium chloride solutions Some protocols mention normal saline (0.9% sodium chloride) as a reconstitution option

Frequently Asked Questions Q: What are MIC B-12 Injections